The prospect of probiotics in -induced peptic ulcer disease: A perspective review


Review Article

Author Details : Biswakanth Kar, Prativa Biswaroy, Debasmita Dubey*, Goutam Rath, Debakanta Mishra, Goutam Ghosh, Shakti Rath

Volume : 10, Issue : 2, Year : 2024

Article Page : 87-94

https://doi.org/10.18231/j.ijmmtd.2024.017



Suggest article by email

Get Permission

Abstract

The relationship between the human host and the intestinal microbiota is dynamic and symbiotic. This review examines whether there is a correlation between a disruption in host-microbial interactions caused by an alternative composition of gut microbiota and an increased susceptibility to peptic ulcer disease, mainly when hazardous bacteria are present in the coexistence. Peptic ulcers frequently arise from infections caused by (), a pathogen that evades the host's immune system and establishes a lifelong colony. This protracted infection gives rise to chronic inflammation, which substantially raises the risk of developing gastric ulcers and gastric cancer. One of the significant obstacles in the treatment of infection is antibiotic resistance, which develops as a result of improper antibiotic treatment for bacterial infections. Such misuse of antibiotics also results in dysbiosis. In such cases, probiotics become an essential tool that restores the balance of the normal flora in the body and eliminates critical infections. This results in probiotics being utilized extensively for ulcer treatment and potentially serving a dual purpose in combating infection; consequently, antibiotic usage will be reduced, and human health will advance.
 

Keywords: Probiotics, Helicobacter pylori, Peptic ulcer disease, Antibiotics


How to cite : Kar B, Biswaroy P, Dubey D, Rath G, Mishra D, Ghosh G, Rath S , The prospect of probiotics in -induced peptic ulcer disease: A perspective review. IP Int J Med Microbiol Trop Dis 2024;10(2):87-94


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







Article History

Received : 26-12-2023

Accepted : 01-05-2024


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmmtd.2024.017


Article Metrics






Article Access statistics

Viewed: 476

PDF Downloaded: 100



Medical Abbreviation List